申请人:HELSINN HEALTHCARE SA
公开号:US10407390B2
公开(公告)日:2019-09-10
Disclosed are compounds, compositions and methods for the prevention and/or treatment of diseases which are pathophysiologically mediated by the ghrelin receptor. The compounds have the general formula (I):
本发明公开了用于预防和/或治疗在病理生理上由胃泌素受体介导的疾病的化合物、组合物和方法。这些化合物具有通式 (I):